To highlight some of the key findings from the JIAS supplement on Advancing use of long‐acting and extended delivery (LAED) HIV prevention and treatment regimens, JIAS held a symposium titled “Advancing Use of Long-Acting HIV Treatment and Prevention Regimens” on February 2, 2024. It offered a comprehensive overview of the ongoing research on long-acting regimens access, delivery, and choice, included community perspectives, discussed future directions, and concluded with a panel discussion.
JIAS Symposium: Advancing Use of Long-Acting HIV Treatment and Prevention Regimens

Kenneth H. Mayer
Professor of Medicine, Director and Co-chair
Harvard Medical School and the Medical Research and Fenway Institute
Annette Sohn
Vice President and Director
TREAT Asia amfAR

Charles Flexner
Professor of Medicine
Johns Hopkins University School of Medicine

Sinéad Delany-Moretlwe
Research professor and research director
Wits RHI at the University of the Witwatersrand, Johannesburg

Kenneth Ngure
Associate Professor
Jomo Kenyatta University of Agriculture and Technology
Ariane van der Straten
Adjunct Professor
University of California San Francisco (UCSF)
Peter Kim
Director
Therapeutics Research Program at the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health
Dianne Rausch
Division of AIDS Research, National Institute of Mental Health, National Institutes of Health

Beatriz Grinsztejn
Head
STD/AIDS Clinical Research Laboratory Fundação Oswaldo Cruz (Fiocruz)